Primary neonatal T cell responses comprise both T helper (
Secondary exposure to antigen (Ag) in neonates usually leads to a lack of Th1 cells and a bias toward Th2 immunity ( 1 -4 ) . This unbalanced response may explain the susceptibility of neonates to microbial infections and allergic reactions ( 5 ) . Strategies aimed at balancing neonatal Th1 and Th2 responses may thus facilitate the development of eff ective vaccines against infections ( 6 ) and treatments for allergies ( 7 ) . Recently, we and others have discovered that both Th1 and Th2 cells develop during the primary response to Ag in neonates ( 8, 9 ) . However, a second encounter with Ag gives rise to a strong Th2 response and a weak Th1 response.
Using OVA-specifi c TCR transgenic (Tg) DO11.10 T cells ( 10 ), we developed a neonate-to-neonate transfer system that allows us to track the fate of primary Th1 cells upon exposure to Ag ( 11 ) . In this system, neonatal splenic T cells from 1-d-old DO11.10/scid mice are transferred into newborn (1-d-old) BALB/c mice, which are then challenged with Ag i.p. 2 wk later, primary T cell responses are evaluated in the spleen. Secondary responses are examined in this model by rechallenging the mice with Ag in CFA at 7 wk of age and analyzing T cell responses 10 d later. Using this model, we have shown that the lack of secondary Th1 responses stems from the apoptosis of Th1 cells driven by IL-4 produced by their Th2 counterparts ( 9 ) . In this system, IL-4 does not signal through the conventional type I IL-4 receptor (IL-4R ␣ / ␥ c ) on Th1 cells ( 12 ) . Rather, primary exposure to Ag induces the up-regulation of the IL-13R ␣ 1 chain, which associates with IL-4R ␣ , giving rise to an IL-4R ␣ /IL-13R ␣ 1 heteroreceptor, or type II receptor, through which both IL-4 and IL-13 can signal ( 13, 14 ) . During in vitro recall or in vivo rechallenge with Ag, IL-4 from the Th2 cells utilizes the IL-4R ␣ /IL-13R ␣ 1 heteroreceptor to drive apoptosis of Th1 cells, thus biasing the secondary immune response toward Th2 cells ( 9 ) .
In this study, we investigated the mechanism underlying the up-regulation of IL-13R ␣ 1 CD8 ␣ + CD4 Ϫ DCs was reversed if IL-12 was neutralized at the time of Ag exposure.
RESULTS

Day 6 after birth represents a turning point for the expression of IL-13R ␣ 1 and the development of neonatal Th1 immunity
Previously, we developed a neonate-to-neonate TCR Tg T cell transfer system that was adapted to overcome the limitations associated with the small size of the newborn mouse and made tracking T cell fate possible ( 8 ) . In this system, neonatal (1-d-old) DO11.10 TCR Tg CD4 T cells that are specifi c for OVA 323 -339 peptide (designated OVA) ( 10 ) are transferred into BALB/c newborns (1 d old), the recipients are exposed to Ag, and the T cells are traced with the TCR-OVA -specifi c anticlonotypic antibody KJ1-26 ( 15 ) and analyzed for response to Ag. Also, as Ag we used Ig-OVA, an Ig chimera expressing OVA peptide within the heavy chain variable region ( 9, 11 ) , for the purpose of avoiding the use of adjuvant ( 4 ) and for optimization of peptide presentation by uptake through Fc ␥ receptors (Fc ␥ Rs) ( 16 ) . As indicated in Fig. 1 , neonatal DO11.10 T cells transferred to 1-d-old BALB/c mice and exposed to Ig-OVA do not produce IFN-␥ upon rechallenge with OVA peptide in CFA at adult stage ( Fig. 1 A ) . When the transfer used 8-wk-old adult instead of neonatal T cells, secondary IFN-␥ responses developed. The lack of a secondary IFN-␥ in neonatal Th1 cells. Our data indicate that the delayed developmental maturation of a subset of DCs leads to a shortage in IL-12 production, allowing for up-regulation of IL-13R ␣ 1 expression and its association with the IL-4R ␣ chain. Indeed, we show that the CD8 ␣ + CD4 Ϫ DCs accumulate to a significant level by day 6 after birth, a time point at which expression of IL-13R ␣ 1 decreases, leading to diminished Th1 cell apoptosis and the restoration of IFN-␥ production by Th1 cells upon secondary Ag challenge. Neutralization of endogenous IL-12 on day 6 restored IL-13R ␣ 1 expression and apoptosis of neonatal Th1 cells, thus inhibiting secondary IFN-␥ responses, and supplying exogenous IL-12 during exposure to Ag at birth decreased IL-13R ␣ 1 expression and inhibited apoptosis of primary Th1 cells, allowing the generation of secondary Th1 responses. Consistent with this, the transfer of wild-type adult DCs into newborn mice that had previously received neonatal DO11.10 T cells inhibited the expression of IL-13R ␣ 1, leading to the survival of primary Th1 cells and the production of IFN-␥ during secondary Ag challenge. In contrast, the transfer of IL-12 -defi cient DCs led to sustained IL-13R ␣ 1 expression, Th1 cell apoptosis, and, thus, a lack of IFN-␥ production during the secondary response. Finally, transfer of IL-12 +/+ , but not IL-12 -defi cient, adult CD8 ␣ + CD4 Ϫ DCs also inhibited IL-13R ␣ 1 expression and Th1 cell apoptosis, and restored secondary IFN-␥ production by Th1 cells. The eff ect of transferring IL-12 +/+ Figure 1 . Neonates acquire the ability to develop secondary Th1 responses when the primary encounter with Ag occurs on or beyond day 6 after birth. Newborn BALB/c mice were given 3 × 10 4 neonatal or adult DO11.10 CD4 T cells and injected with 100 μ g Ig-OVA in saline, and 2 wk later, the splenic cells (10 6 response is because of the fact that neonatal Th1 cells undergo apoptosis upon reencounter with OVA peptide, as indicated by the substantial Annexin V staining relative to adult T cells ( Fig. 1 B ) . However, if neonatal exposure to Ig-OVA occurs around day 6 after birth, the cells acquire the ability to develop secondary IFN-␥ responses both in the spleen and lymph node upon rechallenge with OVA/CFA at the age of 7 wk ( Fig. 1, C and D ) . Overall, neonates acquire the ability to develop Th1 secondary responses when the initial exposure to Ag occurs on or beyond day 6 after birth.
We have previously shown that exposure to Ig-OVA at the neonatal stage induces up-regulation of IL-13R ␣ 1 on Th1 cells and that such a chain associates with IL-4R ␣ to form an IL-4R ␣ /IL-13R ␣ 1 heteroreceptor ( 9 ) through which both IL-4 and IL-13 can signal ( 13, 14 ) . Also, neonatal exposure to Ig-OVA induces both Th1 and Th2 cells in the primary response, and upon rechallenge with OVA peptide the Th2 cells produce IL-4 that uses the IL-4R ␣ /IL-13R ␣ 1 heteroreceptor on Th1 cells to signal for their death ( 9 ) . Because restoration of secondary IFN-␥ responses could occur when the primary exposure to Ig-OVA takes place around day 6 after birth, we sought to test whether at that point in time exposure to Ig-OVA no longer sustains up-regulation of IL-13R ␣ 1 expression. Accordingly, 1-d-old BALB/c mice that had received neonatal DO11.10 T cells were given Ig-OVA on day 1, 2, 4, 6, or 10 after T cell transfer, and 2 wk later their splenic Th1 cells were isolated on the basis of IFN-␥ secretion and tested for IL-13R ␣ 1 mRNA expression. As shown in Fig. 2 A , IL-13R ␣ 1 mRNA was up-regulated when exposure to Ig-OVA took place on day 1, 2, or 4 after birth. However, a signifi cant decrease occurred when the Ig-OVA was given on day 6 or 10 after birth. Densitometry analysis indicated that IL-13R ␣ 1 mRNA went down from 260% of GADPH mRNA on day 2 to 10% on days 6 and 10, indicating an inability of the Th1 cells to up-regulate IL-13R ␣ 1 mRNA ( Fig. 2 B ) . The decrease in IL-13R ␣ 1 mRNA on day 6 after birth translates into reduction of cell-surface IL-13R ␣ 1 protein. Indeed, IL-13R ␣ 1 protein expression went down by 50% (from 91 to 41%) when exposure to Ag was performed on day 6 instead of day 1 after birth ( Fig. 2 C ) . Furthermore, Western blot analysis of Th1 T cell lysates indicated similar results, as Il-13R ␣ 1 decreased by half upon Ag exposure on day 6 instead of day 1 after birth ( Fig. 2 D ) . The control 1C5 CTLL-2 cells transfected with the IL-13R ␣ 1 gene ( 17 ) expressed IL-13R ␣ 1 protein, whereas the untransfected wild-type CTLL cells did not, indicating that the rabbit anti -IL-13R ␣ 1 antiserum is specifi c for IL-13R ␣ 1 protein. Overall, IL-13R ␣ 1 mRNA and protein expression decreased signifi cantly when exposure to Ag was made on day 6 after birth.
When IL-13R ␣ 1 mRNA expression from these Th1 cells during neonatal exposure to Ig-OVA was superimposed upon IFN-␥ production in the secondary response, an inverse correlation between IL-13R ␣ 1 mRNA and the secondary IFN-␥ response was observed ( Fig. 2 C ) . Indeed, when neonatal exposure to Ig-OVA was performed on day 6, the mice began to develop secondary IFN-␥ responses when challenged with The intensity of radioactive spots was analyzed on a Molecular Imager FX using Quantity One software and presented as a ratio of IL-13R ␣ 1 to GAPDH after deduction of the background intensity obtained with pUC19 DNA negative control. The bars represent the mean ± SD of two experiments. (C and D) Newborn BALB/c mice were given 3 × 10 4 neonatal CD4 + DO11.10 T cells and injected i.p. with 60 μ g/g Ig-OVA in saline at day 1 or 6 after birth, and 2 wk later, the splenic cells (10 6 cells/ml) were stimulated for 10 h with 10 μ M OVA peptide. In C, the cells were stained with KJ1-26 and rabbit anti -IL-13R ␣ 1 antiserum (1:100 dilution), and Th1 cells were identifi ed by staining for intracellular IFN-␥ with anti -IFN-␥ antibody. Expression of surface IL-13R ␣ 1 was determined by fl ow cytometry on cells gated for KJ1-26 expression and intracellular IFN-␥ production. In D, Th1 cells were purifi ed as in A, lysed using NP-40 detergent, and run on a 10% acrylamide gel. Transfer was made onto a nitrocellulose membrane, and IL-13R ␣ 1 protein was detected using rabbit anti -IL-13R ␣ 1 antibodies (1:1,000 dilution). For control purposes, we used lysates from CTLL-2 cells transfected with a plasmid coding for cell-surface IL-13R ␣ 1 (reference 17 ) or wild-type untransfected CTLL-2 cells. Band intensity was analyzed using the Molecular Imager FX, and the relative expression of IL-13R ␣ 1 represents a percent ratio with 1 d as 100%. Each bar represents the mean ± SD of duplicate samples. (E) IL-13R ␣ 1 mRNA expression measured by spot intensity from the experiments in A and B is illustrated together with the IFN-␥ production presented in Fig. 1 C to correlate IL-13R ␣ 1 downregulation together with an increase in secondary IFN-␥ production.
does indeed raise Th1 cells ( 8, 9 ) , suggesting that the lack of neonatal secondary Th1 immunity is not due solely to defective diff erentiation. Given that IL-12 was shown to restore neonatal secondary splenic Th1 responses ( 4, 11 ), we thought that it may accomplish this eff ect by interfering with the up-regulation of IL-13R ␣ 1 expression. To test this premise, newborn BALB/c mice were given neonatal DO11.10 T cells and were administered Ig-OVA together with rIL-12. 7 wk later, the animals were challenged with OVA peptide in CFA and their splenic secondary responses were analyzed. As seen in Fig. 3 A , the mice given IL-12 developed IFN-␥ responses, whereas control animals not given IL-12 had no measurable IFN-␥ responses. In line with these results is the observation that the apoptosis of Th1 cells from IL-12 -recipient mice OVA peptide 2 mo later. Such IFN-␥ responses were even higher when the neonatal exposure to Ig-OVA took place on day 10 after birth. Overall, day 6 represents a time point at which exposure to Ag no longer up-regulates IL-13R ␣ 1, leading to the survival of IFN-␥ -producing cells and the development of neonatal Th1 immunity.
Exogenous IL-12 given during exposure to Ag on the day of birth reduces up-regulation of IL-13R ␣ 1 on primary neonatal Th1 cells and restores IFN-␥ secondary responses Previously, it has been shown that neonates demonstrate a poor ability to produce IL-12 ( 18 ) , which justifi es the lack of neonatal Th1 immunity because IL-12 is a key diff erentiation factor for Th1 cells. However, the primary response 
Day 6 transition to Th1 responses is caused by an acquired ability of the neonate to produce IL-12 that down-regulates IL-13R ␣ 1 and sustains the survival of IFN-␥ -producing T cells
Because exogenous IL-12 was able to reduce IL-13R ␣ 1 expression and rescue neonatal primary Th1 cells similar to Ag exposure on day 6, we postulated that the newborn acquires the ability to produce signifi cant IL-12 on day 6, which results in IL-13R ␣ 1 down-regulation and rescue of Th1 immunity. To test this premise, mice were given Ig-OVA and anti -IL-12 antibody on day 6 after birth, challenged with OVA peptide in CFA 2 mo later, and tested for IFN-␥ production as well as Th1 apoptosis. Fig. 4 A shows that neutralization of IL-12 during exposure to Ig-OVA on day 6 reduces IFN-␥ production to minimal levels comparable to those observed with day 1 was signifi cantly reduced relative to control animals not given IL-12 ( Fig. 3 B ) . When the animals were evaluated for IL-13R ␣ 1 expression 2 wk after exposure to Ig-OVA/IL-12 but before any rechallenge with OVA/CFA, the primary Th1 cells had signifi cantly reduced IL-13R ␣ 1 mRNA relative to mice given Ig-OVA but no IL-12, as measured by spot blot ( Fig. 3 C ) and real-time PCR ( Fig. 3 D ) . Again, when the cells were analyzed for IL-13R ␣ 1 protein, the supply of exogenous IL-12 together with Ig-OVA reduced IL-13R ␣ 1 protein expression from 84 to 41% when compared with cells from mice that did not receive IL-12. ( Fig. 3, E and F ) . Overall, exogenous IL-12 was capable of down-regulating IL-13R ␣ 1 on primary Th1 cells, which inhibited their apoptosis during rechallenge with OVA peptide and restored the secondary IFN-␥ responses. Newborn BALB/c mice were given 3 x 10 4 CD4 neonatal DO11.10 T cells within 24 h after birth. On day 6, the hosts were given 60 μ g/g Ig-OVA and 50 μ g anti -IL-12 antibody per mouse or rat IgG. Another injection of anti -IL-12 antibody or rat IgG was given on days 7 and 8. A group of mice that received Ig-OVA on day 1 and no anti -IL-12 antibody at any time was included as a control. 7 wk later, all groups were challenged with 125 μ g OVA peptide in CFA. 10 d later, the splenic cells (10 6 cells/well) were stimulated with 10 μ M OVA peptide and assayed for (A) IFN-␥ production by ELISPOT and (B) apoptosis by Annexin V staining, as in Fig. 3 . Each bar represents the mean ± SD of triplicate wells. (C and D) Mice that received neonatal DO11.10 T cells were given Ig-OVA and anti -IL-12 antibody as in A, and 2 wk later, primary Th1 cells were isolated and IL-13R ␣ 1 expression was assessed by spot blot (C) and real-time PCR (D), as described in Fig. 3 . For the spot blot in C, each bar represents the mean ± SD of duplicate spots. For the real-time PCR, the bars represent the comparative threshold cycle (C T ). The value of the sample from mice that received rat IgG was set as 1. (E and F) Newborn BALB/c from A and B that received anti -IL-12 antibody or rat IgG control during exposure to Ig-OVA on day 6 were killed 2 wk later, and the splenic cells were stained with KJ1-26 and rabbit anti -IL-13R ␣ 1 antiserum (1:100 dilution). The Th1 cells were identifi ed by staining for intracellular IFN-␥ with anti -IFN-␥ antibody, and expression of surface IL-13R ␣ 1 was determined by fl ow cytometry on cells gated for KJ1-26 expression and intracellular IFN-␥ production.
DCs ( 11 ) . It is thus possible that the lack of IL-12 in the neonates is caused by delayed developmental accumulation of DCs. To test this assumption, we enriched the neonates with splenic DCs from adult mice and tested them for rescue of primary neonatal Th1 cells from apoptosis and development of secondary Th1 IFN-␥ responses. As can be seen in ( Fig. 5 D ) . Furthermore, when the mice were challenged with OVA/CFA at 7 wk of age, those recipients of IL-12 +/+ DCs developed secondary IFN-␥ responses, whereas animals that were not given DCs or received IL-12 Ϫ / Ϫ DCs had minimal IFN-␥ responses ( Fig. 5 E ) . The conclusion to be drawn from these experiments is that enrichment with IL-12 +/+ DCs is similar to treatment with exogenous IL-12, which reduces IL-13R ␣ 1 expression by Th1 cells, leading to the inhibition of apoptosis and restoration of secondary IFN-␥ responses.
exposure to Ag, whereas rat IgG -injected mice sustain significant IFN-␥ responses. Also, apoptosis of Th1 cells was more substantial in the mice given anti -IL-12 antibody versus recipients of rat IgG ( Fig. 4 B ) . These results indicate that the restoration of secondary Th1 responses upon delay of Ag exposure to day 6 after birth operates through the production of endogenous IL-12. Interestingly, IL-13R ␣ 1 mRNA expression analyzed 2 wk after day 6 Ag exposure was signifi cantly up-regulated in the mice given anti -IL-12 antibody versus those recipients of rat IgG instead ( Fig. 4, C and D ) . Similar results were observed when the cells were analyzed for IL-13R ␣ 1 protein expression ( Fig. 4, E and F ) . Indeed, neutralization of IL-12 with ant -IL-12 antibody during day 6 exposure to Ig-OVA reduced IL-13R ␣ 1 protein expression from 72 to 43% relative to cells from mice that received the control rat IgG instead of anti -IL-12 antibody. Overall, the fi ndings suggest that the newborn mice acquire the ability to produce signifi cant IL-12 by day 6 after birth that is suffi cient for down-regulation of IL-13R ␣ 1, survival of Th1 cells, and restoration of secondary IFN-␥ responses. Fig. 3 . (D) Groups of mice were killed 2 wk after T cell/DC transfer and exposure to Ig-OVA, and primary Th1 cells were isolated using IFN-␥ secretion kit, as described in Materials and methods. RNA was then extracted and IL-13R ␣ 1 expression was determined by spot blot, as in Fig. 2 . Because IL-13R ␣ 1 mRNA parallels with protein expression (see Figs. 2, 3, and 4 ) , all follow-up experiments will use mRNA analysis on separated Th1 cells. (E) IFN-␥ production was measured using ELISPOT assay. Each bar represents the mean ± SD of duplicate spots.
CD8 + CD4 Ϫ DC transfer is dependent on IL-12. This statement emanates from the observation that IL-12 Ϫ / Ϫ CD8 + CD4 Ϫ DC transfer does not inhibit the apoptosis of Th1 cells ( Fig.  7 F ) , but a supply of exogenous IL-12 together with the IL-12 Ϫ / Ϫ CD8 + CD4 Ϫ DC transfer restores the reduction of Annexin V binding to Th1 cells ( Fig. 7 H ) . Finally, secondary IFN-␥ responses did occur with the IL-12 +/+ CD8 ␣ + CD4 Ϫ DCs, but not with the IL-12 Ϫ / Ϫ CD8 ␣ + CD4 Ϫ or even the Delayed developmental accumulation of the CD8 ␣ + CD4 ؊ subset of DCs in the neonates leads to minimal IL-12 production, signifi cant up-regulation of IL-13R ␣ 1 expression, death of primary Th1 cells, and lack of secondary IFN-␥ responses Because DCs were able to reduce IL-13R ␣ 1 expression, inhibit apoptosis of primary Th1 cells, and restore secondary IFN-␥ responses, we sought to determine whether delayed developmental accumulation of a specifi c subset of DCs is responsible for the up-regulation of IL-13R ␣ 1 by virtue of minimal IL-12 production leading to the death of primary Th1 cells and a lack of secondary IFN-␥ responses. The splenic CD11c + DCs comprise both CD8 ␣ + and CD8 ␣ Ϫ DCs ( 21 ) . Also, some of the CD8 ␣ Ϫ DCs can express CD4, and as such are further divided into CD8 ␣ Ϫ CD4 + and CD8 ␣ Ϫ CD4 Ϫ DCs. Initially, we determined the kinetics of accumulation of various subsets of DCs in the splenic neonate between the day of birth and day 10 of age. As indicated in Fig. 6 , most splenic CD11c + DCs were negative for CD8 ␣ and CD4. However, by day 4 the number of CD8 ␣ Ϫ CD4 + DCs rose to 11.2% among the total CD11c + DCs, whereas CD8 ␣ + CD4 Ϫ DCs made up 3.3% of total CD11c + cells. By day 6, both subsets reached a number that was more or less similar to days 8 and 10, which ranged between 13 and 16% for CD8 ␣ Ϫ CD4 + and between 3.8 and 4.3% for CD8 ␣ + CD4 Ϫ DCs ( Fig. 6 ). These numbers are much lower than those observed in adult mice (40.4% for CD8 ␣ Ϫ CD4 + and 16% for CD8 ␣ + CD4 Ϫ DCs), indicating that developmental accumulation is not complete by day 10. In fact, CD8 ␣ + CD4 + DCs, which make up a very small fraction of total adult CD11c + DCs, remain insignifi cant at day 10 of age. Because day 6 was a turning point for the development of Th1 secondary immunity and the CD8 ␣ Ϫ CD4 + and CD8 ␣ + CD4 Ϫ DC subsets have undergone a signifi cant increase in number between birth and day 6, we tested both popu lations for reduction of IL-13R ␣ 1 up-regulation, inhibition of apoptosis of Th1 cells, and restoration of secondary IFN-␥ responses. Accordingly, newborn BALB/c mice were transferred with 1-dold DO11.10 T cells with the CD8 ␣ Ϫ CD4 + or CD8 ␣ + CD4 Ϫ adult DC subset from either IL-12 +/+ or IL-12 Ϫ / Ϫ mice and were exposed to Ig-OVA. 2 wk later, Th1 cells were isolated and IL-13R ␣ 1 mRNA expression on primary neonatal Th1 cells was evaluated by spot blot. Fig. 7 A shows that up-regulation of IL-13R ␣ 1 expression occurred when the mice received no DC transfer or transfer with IL-12 +/+ CD8 ␣ Ϫ CD4 + DCs. However, up-regulation of IL-13R ␣ 1 expression was minimal when the animals were transferred with IL-12 +/+ CD8 ␣ + CD4 Ϫ DCs ( Fig. 7 A ) . Transfer of IL-12 Ϫ / Ϫ CD8 ␣ + CD4 Ϫ DCs did not reduce IL-13R ␣ 1 mRNA expression on Th1 cells ( Fig.  7 A ) . Moreover, apoptosis of Th1 cells was reduced significantly with the transfer of IL-12 +/+ CD8 ␣ + CD4 Ϫ DCs relative to IL-12 +/+ CD8 ␣ Ϫ CD4 + or no DC transfer ( Fig. 7, C -E ) . Indeed, 83 and 87% of primary Th1 cells bind Annexin V when the transfer used no DCs or IL-12 +/+ CD8 ␣ Ϫ CD4 + DCs, respectively ( Fig. 7, C and D ) . Only 45% of primary Th1 cells bound Annexin V when the transfer was made with IL-12 +/+ CD8 ␣ + CD4 Ϫ DCs ( Fig. 7 E ) . Inhibition of T cell death by DCs, stimulate them with CpG, and test for intracellular IL-12 on gated DC subsets. Fig. 8 B shows that on day 1 after birth most of the splenic DCs are CD8 ␣ Ϫ CD4 Ϫ , with almost no CD8 ␣ + CD4 Ϫ or CD8 Ϫ CD4 + DC subsets. By day 6, however, both CD8 ␣ + CD4 Ϫ and CD8 Ϫ CD4 + DC subsets reached signifi cant frequency, as was shown in Fig. 6 . When tested for intracellular IL-12, 26% of the CD8 ␣ Ϫ CD4 Ϫ double-negative and most frequent subset produced IL-12 on day 1 after birth, and 6 d later 84% of the cells displayed IL-12 expression ( Fig. 8 C ) . This points to a developmental infl uence on these DCs to produce IL-12 cytokine. As for the CD8 ␣ + CD4 Ϫ DCs, like the CD8 ␣ Ϫ CD4 + DCs, there was no detectable IL-12 on day 1 but the majority of the cells available on day 6 produced IL-12 (84 and 97%, respectively; Fig. 8, D and E ) . These results indicate that the limited availability of IL-12 on the day of birth is caused by delayed accumulation of the DC subsets in the spleen, together with a progressive ability to produce IL-12 cytokine.
DISCUSSION
Neonatal exposure to Ag leads to secondary responses that are usually biased toward Th2 upon rechallenge with Ag later ( 1 -4 ).
IL-12 +/+ CD8 ␣ Ϫ CD4 + DC transfer ( Fig. 7 B ) . Supply of exogenous IL-12 with the IL-12 Ϫ / Ϫ CD8 ␣ + CD4 Ϫ DCs restored IFN-␥ secondary responses. Furthermore, neutralization of IL-12 during IL-12 +/+ CD8 ␣ + CD4 Ϫ DC transfer by injection of anti -IL-12 antibody restored apoptosis of primary Th1 cells ( Fig. 7 B ) . These results indicate that CD8 ␣ + CD4 Ϫ DCs provide suffi cient IL-12 needed for down-regulation of IL-13R ␣ 1, inhibition of apoptosis, and restoration of secondary Th1 responses.
To determine whether the limited availability of IL-12 on the day of birth is caused by delayed accumulation of CD8 ␣ + CD4 Ϫ DCs or by an inability of these APCs to produce IL-12, we isolated neonatal CD11c + DCs at diff erent time points after birth, stimulated the cells with the DC stimulator CpG dinucleotide, and tested for IL-12 production. As indicated in Fig. 8 , neonatal DCs gain the ability to produce IL-12 progressively over time and reach a maximum at adult age ( Fig. 8 A ) . However, these results do not distinguish between an increase in the number of CD8 ␣ + CD4 Ϫ DCs or the gain of ability to produce IL-12 cytokine. Given that isolation of the DC subsets at early neonatal age is not feasible because of low frequency, we opted to purify total CD11c + indicated that although CD11c + CD8 ␣ Ϫ CD4 Ϫ DCs were present at a signifi cant number on the day of birth, the CD8 ␣ + CD4 Ϫ and CD8 ␣ Ϫ CD4 + subsets began to accumulate in the spleen by day 4 and reached a signifi cant percentage by day 6 ( Fig. 6 ) . A small population of CD8 ␣ + CD4 + DCs that is present in adult mice was not detected by day 10 after birth. Thus, these observations suggested that it is the CD8 ␣ + CD4 Ϫ and/or the CD8 ␣ Ϫ CD4 + subset that might be responsible for the acquired ability of the neonate to develop secondary Th1
Recent investigations indicated that both Th1 and Th2 cells develop in the neonatal primary response, but secondary encounter with Ag leads to death of the Th1 cells by apoptosis, hence the bias toward Th2 cells ( 9 ) . The death of Th1 cells stems from an up-regulation of the IL-13R ␣ 1 chain during neonatal exposure to Ag ( 9 ) . Indeed, it was shown that the IL-13R ␣ 1 chain associates with IL-4R ␣ to form an IL-4R ␣ / IL-13R ␣ 1 heteroreceptor through which both IL-4 and IL-13 cytokines can signal ( 13, 14 ) . During rechallenge with Ag, IL-4 from the Th2 cells utilizes the IL-4R ␣ /IL-13R ␣ 1 heteroreceptor and induces the death of Th1 cells ( 9 ) . In this paper, we show that day 6 after birth is a turning point at which exposure to Ag no longer results in secondary responses that are biased toward Th2 and secondary Th1 IFN-␥ responses emerge ( Fig. 1 ) . These observations bode well with fi ndings indicating that exposure to Ag at day 7 but not at day 3 become eff ective in inducing Th1 responses ( 22 ) . Interestingly, day 6 after birth also represents a turning point for the expression of IL-13R ␣ 1, as exposure to Ag at this age no longer up-regulates IL-13R ␣ 1 mRNA or protein expression on Th1 cells ( Fig. 2 ) . We then set up experiments and investigated the mechanism underlying the restoration of neonatal Th1 secondary responses by day 6 Ag exposure. We have previously shown that IL-12 can rescue splenic Th1 cells and restore IFN-␥ production ( 4, 11 ) . Given that the neonate displays an inability to produce signifi cant IL-12 ( 19, 23 ) , we thought that exposure to Ag within an environment where IL-12 is limited may be responsible for up-regulation of IL-13R ␣ 1 and the consequent death of Th1 cells. This assumption proved correct, as exogenous IL-12 given during Ag exposure on day 1 reduced IL-13R ␣ 1 mRNA and protein expression on primary Th1 cells, inhibited their apoptosis, and restored secondary IFN-␥ responses ( Fig. 3 ) . Moreover, it was shown that the administration of anti -IL-12 antibody during Ag exposure on day 6 after birth nullifi es restoration of secondary IFN-␥ responses, and this operates through the restitution of IL-13R ␣ 1 up-regulation and apoptosis of Th1 cells ( Fig. 4 ) .
Given that DCs are the main producers of IL-12 and that the neonatal environment is composed of lower numbers of DCs relative to other APCs ( 11 ), it is possible that the inability of the neonatal environment to provide signifi cant IL-12 is related to the minimal number of Ag-presenting DCs available at day 1 after birth. In fact, when newborn mice were enriched with adult IL-12 +/+ splenic DCs, up-regulation of IL-13R ␣ 1 on primary Th1 cells was minimal, apoptosis was signifi cantly reduced, and secondary Th1 IFN-␥ responses were restored ( Fig. 5 ) . IL-12 Ϫ / Ϫ DCs could not inhibit IL-13R ␣ 1 up-regulation or restore Th1 IFN-␥ responses. These observations, together with the day 6 -acquired neonatal transition to secondary Th1 responses, suggest that developmental accumulation of DCs could be responsible for the bias of neonatal immunity toward Th2. Given that distinct subsets of DCs can perform diff erent functions ( 24 -27 ) , delayed developmental accumulation of a specifi c subset of CD8 ␣ +/ Ϫ CD4 +/ Ϫ DCs over time could orchestrate the Th2 bias of neonatal immunity. Analysis of DC ontogeny in the neonate mouse Newborn BALB/c mice were killed at the indicated day after birth, and splenic CD11c + DCs were isolated on anti-CD11c microbeads. (A) The DCs (100 × 10 3 cells per well) were stimulated with 6 μ g/ml CpG, and 24 h later, IL-12 was measured by ELISA. Each bar represents the mean ± SD of triplicate wells. (B -E) 1-and 6-dold DCs (100 × 10 3 cells per well) were purifi ed from the spleens of 45 newborns, and 10 6 CD11c + cells were stimulated with 6 μ g/ml CpG for 10 h, after which BFA was added and the culture was continued for 4 h to facilitate intracellular cytokine accumulation. Subsequently, the cells were stained with anti-CD11c, anti-CD4, and anti-CD8 antibodies and permeabilized with 2% saponin. Intracellular IL-12 was detected by staining with anti -IL-12 p70 antibody. B shows the frequency of the subsets, and C -E illustrates fl ow cytometry plots of intracellular IL-12 on the indicated subset. ND, not detected.
were conducted according to the guidelines of the University of Missouri Columbia Animal Care and Use Committee.
Ag ' s
OVA peptide (SQAVHAAHAEINEAGR) encompasses aa residues 323 -339 of OVA and is immunogenic in BALB/c (H-2 d ) mice. Ig-W, a BALB/c IgG2b Ig molecule generated by transfection of the 91A3 antiarsonate antibody heavy and light chains into the non -Ig-secreting myeloma B cell line SP2/0, was previously described ( 4 ). Ig-OVA, expressing OVA peptide within the heavy chain variable region of Ig-W, was also previously described ( 11 ) . ODN1826 or CpG oligonucleotide was purchased from InvivoGen.
Generation of rabbit anti -IL-13R ␣ 1 antibodies
Expression and purifi cation of IL-13R ␣ 1 protein. The plasmid pQE30 -IL-13R ␣ 1 ( 31 ), a gift from A. Gessner (Institut f ü r Klinische Mikrobiologie, Immunologie und Hygiene, Erlangen, Germany), was digested with SphI and XhoI to liberate a cDNA that encodes the extracellular domain of IL-13R ␣ 1 (aa 27 -339) with an N-terminal His tag. This fragment was ligated into pFastBac plasmid (Invitrogen) to generate pFastBac -IL-13R ␣ 1, which was then used to generate baculovirus and to express rmIL-13R ␣ 1 in Sf9 cells, according to the manufacturer ' s instructions. IL-13R ␣ 1 protein was purifi ed using Ni-NTA agarose beads from QIAGEN, as previously described ( 32 ) .
Rabbit immunization with IL-13R ␣ 1 protein.
A New Zealand white rabbit was immunized with 50 μ g rIL-13R ␣ 1 in CFA/PBS, as previously described ( 33 ) . A subsequent immunization with 50 μ g rIL-13R ␣ 1 in IFA/PBS was given monthly for 3 mo.
Adoptive T cell transfer
Splenic cells from 1-day-old DO11.10/scid mice containing the equivalent of 30 × 10 3 DO11.10 T cells were transferred into 1-day-old BALB/c mice by i.v. injection through the facial vein using a 30-gauge needle. To obtain four experimental newborn BALB/c hosts, 12 DO11.10/scid neonatal mice were used. For the transfer of adult T cells into newborn mice, DO11.10 T cells were purifi ed from the spleens of adult DO11.10/scid mice with anti-CD4 antibody -coupled magnetic beads (Miltenyi Biotec) before injection into the host. In this case, two to three adult DO11.10/ scid mice are needed to generate four neonatal BALB/c hosts. When the analysis requires separation of Th1 from Th2 cells, the transfer used 300 × 10 3 purifi ed rather unseparated neonatal DO11.10/scid T cells. In this case, 60 newborn DO11.10/scid mice are needed to generate four BALB/c hosts. This 10-fold increase in T cell transfer was required for the isolation of suffi cient numbers of T cells for RNA extraction and spot blot and realtime PCR analysis.
Detection of apoptosis by staining with Annexin V
For cell-surface staining, the splenic cells from BALB/c hosts that received neonatal DO11.10/scid T cells and Ig-OVA were incubated for 20 min at 4 ° C with 5 μ g/ml 2.4G2 mAb to block Fc ␥ Rs on the cell surface before staining. The cells were then stained with the anti-TCR OVA clonotypic mAb KJ1-26 (mouse IgG2a) and FITC -Annexin V (BD Biosciences). Cytokine secretion was blocked by the addition of 10 μ g/ml Brefeldin A (BFA; Epicentre), and the cells were fi xed with 2% formaldehyde, permeabilized with 2% saponin (Sigma-Aldrich) in PBS buff er for 10 min at room temperature, and incubated with PE -anti -mouse IFN-␥ . Isotype-matched controls were included in all experiments. All data were collected using a fl ow cytometer (FACScan; Becton Dickinson) and were analyzed with CellQuest software (Becton Dickinson) and Flowjo software (Tree Star, Inc.).
Separation of Th1 cells
The separation of neonatal Th1 from Th2 cells requires an increased frequency of primary T lymphocytes. To overcome this technical diffi culty, the transfer was performed with purifi ed neonatal DO11.10/scid T lymphocytes instead of total splenic cells, and the number of transferred cells was increased from 30 to 300 × 10 3 cells per newborn BALB/c host. Consequently, each T cell subset responses when exposure to Ag is performed on day 6 after birth. In fact, when the CD8 ␣ + CD4 Ϫ , but not the CD8 ␣ Ϫ CD4 + , subset was transferred to newborns on the day of birth during exposure to Ag, the primary Th1 cells displayed signifi cantly reduced IL-13R ␣ 1 expression, resisted apoptosis, and developed secondary IFN-␥ responses when the animals were rechallenged with OVA as adults ( Fig. 7 ) . Transfer of IL-12 Ϫ / Ϫ CD8 ␣ + CD4 Ϫ DCs was not able to overturn IL-13R ␣ 1 upregulation or restore IFN-␥ secondary Th1 responses, indicating that the subset presents Ag and produces the IL-12 needed to counter IL-13R ␣ 1 up-regulation. Moreover, investigation of the frequency of the DC subsets indicated that a minimal number of the presenting CD8 ␣ + CD4 Ϫ DC subset is present in the spleen on the day of birth. At best, these cells could produce IL-12 at a limited rate, like the CD8 ␣ Ϫ CD4 Ϫ double-negative DC subset ( Fig. 8 ), but this would be insuffi cient to counter IL-13R ␣ 1 up-regulation. By day 6, the frequency of the CD8 ␣ + CD4 Ϫ DC subset increased because of signifi cant accumulation of this subset ( Fig. 8 ) . In addition, most of the cells produced IL-12, leading to inhibition of IL-13R ␣ 1 up-regulation, diminished apoptosis of primary Th1 cells, and development of secondary Th1 responses.
Collectively, these observations indicate that delayed developmental maturation of a subset of DCs operates the Th2 bias of neonatal immunity. In particular, our data suggest that minimal production of IL-12 in early neonatal life because of delayed accumulation of the CD8 ␣ + CD4 Ϫ DC subset leads to up-regulation of IL-13R ␣ 1 on primary Th1 cells. This chain associates with IL-4R ␣ and forms an IL-4R ␣ /IL-13R ␣ 1 heteroreceptor ( 13, 14 ) . IL-4 from the Th2 cells used this receptor to drive apoptosis of Th1 cells, leading to a lack of secondary Th1 immunity, and hence the bias to Th2 cells ( 9 ) . These observations agree with previous papers showing a delayed developmental accumulation of DCs ( 28, 29 ) . What this study adds is that a specifi c subset is responsible for Ag presentation and IL-12 production, and it ties the regulation of IL-13R ␣ 1 to such IL-12 and the developmental maturation of the CD8 ␣ + CD4 Ϫ DC subset during the neonatal period. Also, we demonstrate that suffi cient accumulation of the CD8 ␣ + CD4 Ϫ DC subset by day 6 after birth represents a turning point to down-regulate IL-13R ␣ 1 and sustain the transition for Th1 responses. These previously unrecognized fi ndings highlight the mechanism underlying the bias of neonatal immunity toward Th2 cells and provide useful information for the development of pediatric vaccines and reagents against allergies in infants and children ( 30 ) .
MATERIALS AND METHODS Mice
BALB/c (H-2 d ) mice were purchased from Harlan Sprague Dawley and were used as hosts for the adoptive transfer of T cells. DO11.10/scid Tg mice expressing a TCR specifi c for OVA peptide ( 10 ) were used as T cell donors. IL-12 Ϫ / Ϫ mice in which the IL-12p35 gene was knocked out ( 20 ) were obtained from the Jackson Laboratory and were used as a source for DC transfer. New Zealand white rabbits were purchased from Myrtle ' s Rabbitry. All animals were maintained in the animal facility for the duration of the experiments. Experimental procedures performed on these animals
Spot blot for detection of IL-13R ␣ 1 expression
Because of the small number of isolated Th1 cells, RNA purifi cation yields small amounts insuffi cient to perform Northern blot analysis. We developed a spot-blot technology to overcome these limitations and performed IL-13R ␣ 1 analysis by both spot blot and real-time PCR. Accordingly, a 1-kb IL-13R ␣ 1 DNA fragment was digested from pCEP4IL-13R ␣ 1 plasmid with BamH1 and purifi ed by electroelution from a 1% agarose gel. 1 μ l Tris buff er containing 5 ng IL-13R ␣ 1, pUC19 or GAPDH DNA was deposited within marked circular spots on a nylon transfer membrane (Magnacharge; Osmonics). Duplicate spots were made for each sample. The membrane was dried for 30 min at 60 ° C, and the DNA was denatured in 0.5 N NaOH and neutralized with 0.5 M Tris buff er. The membrane was then used for detection of IL-13R ␣ 1 mRNA. Total RNA was extracted from 0.5 -1 × 10 6 purifi ed Th1 cells using TRI zol reagent (Life Technologies). 5 μ g RNA was used in an RT reaction together with ␣ -[ 32 P]dCTP (GE Healthcare) to generate labeled cDNA probes by using the Ampolabeling-LRP kit (SuperArray Inc.). The specifi c primers for the amplifi cation of target genes were purchased from SuperArray Inc. Subsequently, the labeled cDNA probes were hybridized to the membrane in a 0.75-ml hybridization buff er for 24 h at 60 ° C. The intensity of radioactive spots was analyzed on a Molecular Imager FX (Bio-Rad Laboratories) using Quantity One software. Results were expressed as arbitrary units estimated as follows: (mean spot density of sample Ϫ mean spot density of background)/(mean spot density of GAPDH Ϫ mean spot density of background). The background represents the mean radioactive intensity obtained from pUC19 DNA spots included in the membrane.
Real-time PCR
RT and DNA amplifi cation were performed according to a one-step protocol using 200 ng of total RNA and an Absolute MAX QRT-PCR SYBR Mix (ABgene), according to the manufacturer ' s instructions. Expression of IL-13R ␣ 1 chain mRNA was assessed in neonatal Th1 cells. ␤ -actin was included to serve as a normalizer. The oligonucleotides used as specifi c primers were as follows: sense, (IL-13R ␣ 1) 5 Ј -GCACAGAGTATAGGTA-AGGAGCAA-3 Ј and ( ␤ -actin) 5 Ј -AGAGGGAAATCGTGCGTGAC-3 Ј ; and antisense, (IL-13R ␣ 1) 5 Ј -ACAAAGACTGGAATGGTGAGTAAC-3 Ј and ( ␤ -actin) 5 Ј -CAATAGTGATGACCTGGCCGT-3 Ј . Real-time PCR was performed on a Smart Cycler (Cepheid), and the results were analyzed by the comparative C T method described by the Smart Cycler software.
Cytokine ELISA and ELISPOT
Measurement of cytokines by ELISA. Splenic cells containing both T cells and APCs were incubated with Ag in 96-well round-bottom plates for 24 h. IFN-␥ production was measured by ELISA using anticytokine antibodies according to BD Bioscience ' s instructions.
Measurement of IFN-␥ by ELISPOT.
Detection of IFN-␥ by ELISPOT was performed as previously described ( 4, 9 ) . In brief, HA-Multiscreen plates (Millipore) were coated with capture antibody, and free sites were saturated with DMEM culture media containing 10% fetal calf serum. Subsequently, 10 6 splenic cells were added and the culture was stimulated with OVA peptide with or without blocking antibody. 1 μ g/ml of biotinylated anti -IFN-␥ antibody was added, and bound antibody was revealed with avidin-peroxidase. Spots were counted using Immunospot software (Cellular Technology Ltd.).
